Interleukin-2 in clinical trials: other factors to be considered.
Nannini
E C
EC
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D007376:Interleukin-2